Compare ADMA & NBTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ADMA | NBTB |
|---|---|---|
| Founded | 2004 | 1856 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.4B |
| IPO Year | 2012 | 1995 |
| Metric | ADMA | NBTB |
|---|---|---|
| Price | $8.75 | $49.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $25.67 | ★ $51.33 |
| AVG Volume (30 Days) | ★ 3.3M | 316.3K |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.39% |
| EPS Growth | N/A | ★ 12.12 |
| EPS | 0.19 | ★ 0.98 |
| Revenue | $42,219,783.00 | ★ $182,952,000.00 |
| Revenue This Year | $27.46 | $16.82 |
| Revenue Next Year | $22.11 | $4.88 |
| P/E Ratio | ★ $45.89 | $50.27 |
| Revenue Growth | ★ 43.85 | 10.40 |
| 52 Week Low | $7.21 | $39.21 |
| 52 Week High | $20.46 | $49.49 |
| Indicator | ADMA | NBTB |
|---|---|---|
| Relative Strength Index (RSI) | 52.30 | 66.55 |
| Support Level | $7.38 | $41.60 |
| Resistance Level | $8.90 | N/A |
| Average True Range (ATR) | 0.33 | 1.05 |
| MACD | 0.12 | 0.17 |
| Stochastic Oscillator | 67.24 | 82.06 |
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.
NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. Its business, predominantly conducted through NBT Bank, consists of providing commercial banking, retail banking, and wealth management services to customers in its market area, which includes upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont, southern Maine, and central and northwestern Connecticut. The company's reportable segments are Banking and Retirement Plan Administration. A majority of its revenue is generated from the Banking segment.